Association of apolipoprotein J gene 866C→T polymorphism with preeclampsia and essential hypertension

Gynecologic and Obstetric Investigation

Volumn 60, Issue 3, 2005, Pages 133-138

  Chen, MiaoXin ^a   Yuan, ZhuHua ^a   Shan, KeRen ^a  

^a GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Apolipoprotein J; Essential hypertension; Genetic polymorphism; Preeclampsia

Indexed keywords

CLUSTERIN;

ADULT; ALLELE; ARTICLE; CHINA; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ESSENTIAL HYPERTENSION; EXON; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREVALENCE; PRIORITY JOURNAL;

ADULT; AMINO ACID SEQUENCE; CASE-CONTROL STUDIES; CHINA; CLUSTERIN; CYTOSINE; DNA MUTATIONAL ANALYSIS; ELECTROPHORESIS; EXONS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREVALENCE; THYMINE;

EID: 26444596743     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086056     Document Type: Article

References (36)

1. National High Blood Pressure Education Working Group Report on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 1990;163:1689-1712.
2. Harrison GA, Humphrey KE, Jones N, et al: A genomewide linkage study of preeclampsia/eclampsia reveals evidence for a candidate region on 4q. Am J Hum Genet 1997;60:1158-1167.
3. Arngrimsson R, Bjornsson S, Geirsson RT, et al: Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population. Br J Obstet Gynaecol 1990;97:762-769.
4. Kobashi G: A case-control study of pregnancy-induced hypertension with a genetic predisposition: Association of a molecular variant of angiotensinogen in the Japanese woman in Hokkaido. Igaku Zasshi 1995;70:649-657.
5. Dekker GA, Sibai BM: Etiology and pathogenesis of preeclampsia: Current concepts. Am J Obstet Gynecol 1998;179:1359-1375.
6. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA: Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. Hypertension 2001;38:718-722.
7. Wang J, Mimuro S, Lahoud R, et al: Elevated levels of lipoprotein(a) in women with preeclampsia. Am J Obstet Gynecol 1998;178:145-149.
8. Risto K, Matti JT, Lasse Viinikka, et al: Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet Gynecol 1995;85:353-356.
9. Stattar N, Bendonir A, Berry C, et al: Lipoprotein subfraction concentrations in preeclampsia: Pathogenic parallels to atherosclerosis. Obstet Gynecol 1997;89:403-408.
10. Belo L, Caslake M, Gaffney D, et al: Changes in LDL size and HDL concentration in normal and preeclamptic pregnancies. Atherosclerosis 2002;162:425-432.
11. Khaliq F, Singhal U, Arshad Z, et al: Study of serum lipid and lipoprotein in pre-eclampsia with special reference to parity. Indian J Physiol Pharmacol 2000;44:192-196.
12. De Messias-Reason IJ, Aleixo V, de Freitas H, et al: Complement activation in Brazilian patients with preeclampsia. J Investig Allergol Clin Immunol 2000;10:209-214.
13. Haeger M: The role of complement in pregnancy-induced hypertensive disease. Int J Gynaecol Obstet 1993;43:113-127.
14. De Silva HV, Stuart WD, Duvic CR, et al: A 70-kDa apolipoprotein designated apo J is a marker for subclasses of human plasma high density lipoproteins. J Biol Chem 1990;265:13240-13247.
15. Kelso GJ, Stuart WD, Richter RJ, et al: Apo lipoprotein J is associated with paraoxonase in human plasma. Biochemistry 1994;33:832-839.
16. Blatter MC, James RW, Messmer S, et al: Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase. Eur J Biochem 1993;211:871-879.
17. Tschopp J, French LE: Clusterin: Modulation of complement function. Clin Exp Immunol 1994;97(suppl 2):11-14.
18. Rosemberg ME, Silkensen J: Clusterin: Physiologic and pathophysiologic considerations. Int J Biochem Cell Biol 1995;115:243-253.
19. Jenne DE, Lowin B, Peitsch MC, et al: Clusterin (complement lysis inhibitor) forms a high density lipoprotein complex with apo lipoprotein A-I in human plasma. J Biol Chem 1991;266:11030-11036.
20. Wong P, Taillefer D, Lakins J, et al: Molecular characterization of human TRPM-2/clusterin, a gene associated with sperm maturation, apoptosis and neurodegeneration. Eur J Biochem 1994;221:917-925.
21. Lea M, Guan Z, Meenakshi M, et al: Apo lipoprotein J/clusterin limits the severity of murine autoimmune myocarditis. J Clin Invest 2000;106:1105-1113.
22. Aronow BJ, Lund SD, Brown TL, et al: Apo lipoprotein J expression at fluid-tissue interfaces: Potential role in barrier cytoprotection. Proc Natl Acad Sci USA 1993;90:725-729.
23. Jenkins SH, Stuart WD, Harmony JAK, et al: Development of competitive enzyme-linked immunosorbent assay for a new apo protein (J). Clin Chem 1990;36:963.
24. Hannaford P, Ferry S, Hirsch S: Cardiovascular sequelae of toxemia of pregnancy. Heart 1997;77:154-158.
25. Seely EW: Hypertension in pregnancy: A potential window into long-term cardiovascular risk in women. J Clin Endocrinol Metab 1999;84:1858-1861.
26. Wilson BJ, Watson MS, Prescott GJ, Sunderland S, Campbell DM, Hannaford P, Smith WCS: Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: Results from cohort study. BMJ 2003;326:845.
27. Nalogowska-Glosnicka K, Lacka BI, Zychma MJ, et al: Angiotensin II type 1 receptor gene A1166C polymorphism is associated with the increased risk of pregnancy-induced hypertension. Med Sci Monit 2000;6:523-529.
28. Kamboh MI, Harmony JA, Sepehrnia B, Nwankwo M, Ferrell RE: Genetic studies of human apolipoproteins. XX. Genetic polymorphism of apolipoprotein J and its impact on quantitative lipid traits in normolipidemic subjects. Am J Hum Genet 1991;49:1167-1173.
29. Tycko B, Feng L, Nguyen L, Francis A, Hays A, Chung WY, Tang MX, Stern Y, Sahota A, Hendrie H, Mayeux R: Polymorphisms in the human apolipoprotein-J/ clusterin gene: Ethnic variation and distribution in Alzheimer's disease. Hum Genet 1996;98:430-436.
30. ACOG Practice Bulletin No 33: Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 2002;99:159-167.
31. Guidelines Subcommittee: 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999;17:151-183.
32. Budowle B, Chakraborty R, Giusti AM, et al: Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE. Am J Hum Genet 1991;48:137-144.
33. Wong P, Taillefer D, Lakins J, Pineault J, Chader G, Tenniswood M: Molecular characterization of human TRPM-2/clusterin, a gene associated with sperm maturation, apoptosis and neurodegeneration. Eur J Biochem 1994;221:917-925.
34. Nagy B, Rigo J Jr, Fintor L, et al: Apolipoprotein E alleles in women with severe pre-eclampsia. J Clin Pathol 1998;51:324-325.
35. Makkonen N, Heinonen S, Hiltunen M, et al: Apolipoprotein E alleles in women with preeclampsia. J Clin Pathol 2001;54:652-654.
36. Dean M, Stephens JC, Winkler C, Lomb DA, Ramsburg M, Boaze R, Stewart C: Polymorphic admixture typing in human ethnic populations. Am J Hum Genet 1994;55:788-808.